Synbio Manufacturing Innovation Institute Stakeholders Meeting

The EBRC is hosting a Synbio MII Stakeholders Meeting on January 24, 2020 in Houston, TX. We will outline our general vision for the institute and discuss community needs. Specifically, we will host a dialogue on Membership & Structure, R&D Planning, Institute Capacity Needs, Location, IP & Data Sharing, and Workforce Development. We will use input from this meeting to draft a framework of the Institute for community feedback, continued dialogue, and ultimately to create of a strong, proposing team.

As outlined in the U.S. Department of Defense recent Request for Information and Notice of Intent, the FOA will request the Synbio MII focus on innovations in biomanufacturing non-biomedical products, be structured to address both DoD and commercial applications, and focus on maturing technologies from TRL 4 to 7.

Read our Dear Colleagues Letter

This meeting is open to relevant biomanufacturing stakeholders and is subject to capacity limits. Organizations not US-owned and operated inside the United States should contact SynbioMII@ebrc.org prior to registering. Advance registration is required.

Update (17 Jan): Registration is nearly at capacity. If you would like to participate, please email SynbioMII@ebrc.org and we will do our best to accommodate you.

Updated Meeting AgendaRead our Q&A

IMPORTANT DATES

  • January 17, 2020 – Last day to register, if we don’t reach capacity beforehand.
  • January 24, 2020 – Meeting will run from 8:30 AM to 4:00 PM. (We recommend a departing flight after 5:30 PM to fully participate)

WORKSHOP VENUE & HOST HOTEL INFORMATION:

Houston Airport Marriott at George Bush Intercontinental 
18700 John F Kennedy Blvd, Houston, TX 77032 | 281-443-2310

Negotiated room rate: $159/night plus taxes/fees [A link will be provided when your registration is accepted.]

Point of Contact

You may contact the EBRC Team at SynbioMII@ebrc.org

NSTC Interagency Synthetic Biology Workshop

This workshop is an invitation-only event.

Venue & Registration

Bethesda North Marriott Hotel and Conference Center

5701 Marinelli Road, Rockville, MD 20852

Secure Online Event Registration

Meeting Overview

This workshop is the beginning of an exercise across federal agencies that fund synthetic biology to coordinate activities and look for opportunities that will catalyze the science and technology in this space.  As such, the workshop is designed around a set of workshop case studies and the EBRC Roadmap.

Please see the workshop goals to learn more about the workshop objectives.

Workshop the attendees include approximately 30 experts from academia and industry and 30-50 policy makers and subject matter experts from inside the US government.

Please send any questions to helix@ebrc.org.

Agenda & Other Materials

Agenda

Workshop Goals

Workshop Case Studies

Case Studies: Biomanufacturing

Case Studies: Bioenergy Agriculture

Case Studies: Medicine

Case Studies: Cellular Factories

SBA 2019 Conference – Synthetic Biology Australasia (SBA)

SBA2019 will be held Monday 14th – Wednesday 16th October 2019 in sunny Brisbane, Australia.The conference will provide a forum for academic and industry researchers to present the latest research findings and describe emerging technologies and directions in synthetic biology. Leading international and Australian scientists will present, and we have a strong commitment to providing presentation opportunities for early and mid-career researchers. There will be plenty of opportunities for networking, and we invite scientists from all related disciplines to attend.The program includes both biophysical and social science, as well as industry presentations.

We encourage submissions across a range of biophysical science topics, including (but not limited to): genetic circuitry, high throughput engineering, pathways and products, metabolic engineering, tools, computational synbio, iGEM, etc.; as well as application areas including diagnostics, health, environment, agriculture, food, and commercialisation. In the social sciences, submissions are encouraged in areas including (but not limited to): psychology, behavioural economics, bioethics, bioart, sociology, anthropology, legal studies, science & technology in society, responsible innovation, and ethics.

SBA 2019 is co-hosted by The University of Queensland (through the Australian Institute for Bioengineering and Nanotechnology) and the CSIRO Synthetic Biology Future Science Platform. We have partnered with the Australian Academy of Science to support an ECR Forum on Synthetic Biology Commercialisation.

SBA members get substantial discounts on registration; ECRs (student and post-doc) members of SBA are eligible to apply for travel awards of $250 (membership can be purchased here). Registration places are limited, so please register early to avoid disappointment. We look forward to welcoming you in Brisbane!

Synberc (Synthetic Biology Research Center)

You have been redirected from synberc.org

Synberc: Building the Future with Biology (Synberc 10 Year Book)

About Synberc

Synberc was a multi-university research center established in 2006 and funded for ten years with a grant from the National Science Foundation (NSF) to help lay the foundation for synthetic biology. During its 10 years of NSF support, Synberc made important early contributions to the development of the field of synthetic biology through research from members’ labs, interactions between academic and industry members, and broad-impact activities to support socially responsible innovation. At the conclusion of Synberc’s grant period, the Engineering Biology Research Consortium (EBRC) was founded. Many of the key activities established by Synberc have been adopted, improved, and continued by EBRC. EBRC is continuing to develop additional new activities and programs to support and sustain the impact of research, products, discoveries, and ideas from the synthetic biology community.

Synberc’s mission was threefold:

  1. develop the foundational understanding and technologies to build biological components and assemble them into integrated systems to accomplish many particular tasks;
  2. train a new cadre of engineers who will specialize in synthetic biology; and
  3. engage the public about the opportunities and challenges of synthetic biology.

Just as electrical engineers have made it possible to assemble computers from standardized parts (hard drives, memory cards, motherboards, and so on), Synberc envisioned a day when biological engineers systematically assembled biological components such as sensors, signals, pathways, and logic gates to build bio-based systems that solve real-world problems in health, energy, and the environment.

Synberc researchers applied engineering principles to biology to develop tools to improve how fast — and how well — synthetic biologists could go through the design-test-build cycle. These included smart fermentation organisms that can sense their environment and adjust accordingly, and multiplex automated genome engineering, or MAGE, designed for large-scale programming and evolution of cells. Synberc also pursued the discovery of applications that would lead to significant public benefit, such as synthetic artemisinin, an anti-malaria drug that costs less and is more effective than former plant-derived treatment.

History

In 2006, motivated by the possibility that microbes could be systematically engineered to produce virtually any product from sugar, a group of leading synthetic biologists successfully proposed Synberc to the National Science Foundation. Synberc was a ten-year multi-institutional research project working to lay the foundations for the field of synthetic biology which was emerging at the time. Synberc grew a trusted network of academic researchers working on foundational tools and technologies with a research program that created the enabling tools and technologies that have given rise to many bio-based applications. Synberc’s integrated Policy & Practices group developed and promoted leading examples of responsible synthetic biology research and application in four areas: biosafety and biosecurity; environmental applications and regulation; ownership, sharing and innovation; and community and leadership development. Synberc also built a robust industry partnership that includes nearly 50 small and large companies, non-profits, and industry associations.

With its federal funding ending in 2016, Synberc called upon the federal government to work with academic and industrial researchers to launch a national initiative in engineering biology and thus the Engineering Biology Research Consortium (EBRC) was launched to sustain and coordinate federal investments, coordinate regulatory and safety policies, catalyze public-private partnerships, and encourage education programs to create leaders in biotechnology practice and policy.

Research

Synberc’s research programs focused on projects that developed the foundational understanding and technologies needed to routinely build large numbers of useful biological systems from standard interchangeable parts. Synberc also developed a set of collaborative, cross-cutting testbed projects that drove the development of tools and technologies, and provided proof of principle in building complex applications for real-world problems.

Overview

Synberc’s research program focused on the development of:

PARTS – The most basic unit in the design of synthetic biological systems

DEVICES – Engineered genetic objects that are designed to function under specified conditions, and that can be created by combining parts

CHASSIS – Host cells that are designed to run a genetic program.

PRACTICES – Policies, procedures and ways of thinking about ethical, legal and social issues, as well as safety and security.

TESTBEDS – Synberc developed several testbeds to test the integration of Parts, Devices, Chassis and Practices into an integrated application to solve a particular societal challenge.  These testbeds ranged from tumor-destroying bacteria to chemical-producing microbes to nitrogen-fixing plants. Many of these testbeds were inspired by industry needs.

Synberc’s specific goals were to:

  • Develop a conceptual framework for designing small biological components, or parts, that could be assembled into devices to perform a well-characterized function under specified conditions;
  • Develop chassis (assembly substrate and power supply) to host the engineered devices and to assemble several devices as “systems” that accomplish a larger objective or goal ;
  • Develop a set of standards for the interactions of the parts and devices so that devices can be built more readily and reproducibly (enabling composition);
  • Offer the parts, devices, and chassis as open source to other researchers and companies; and
  • Link these engineering goals within a comprehensive practices framework.

In addition to the thrusts and testbeds highlighted above, Synberc developed a core of cross-cutting research that provided foundational tools and technologies to advance synthetic biology internally and externally. These projects include automated DNA construction, models and design, safety and security, and registries and repositories.

Research Resources

Synberc facilitated the development of a number of research resources for the synthetic biology community. These resources can be accessed on the EBRC Resources page.

EBRC 2019 Global Forum for Engineering Biology: Initial Review of Synthetic Biology National Strategies

This workshop is an invitation-only event.

VENUE

Chaminade Resort & Spa 

One Chaminade Lane, Santa Cruz, CA 95065

MEETING OVERVIEW

The EBRC Global Forum is an international summit on national synthetic biology roadmaps and strategies. Our goal is to bring together leading representatives from more than 15 countries with active synthetic biology national strategies, programs, and roadmaps. It is an opportunity for international leaders in the field to present and discuss national strategies for synthetic or engineering biology in a relaxed, not-for-attribution forum.

The agenda of two full days includes plenary sessions to exchange information and to review key international and national trends, developments, and themes shaping engineering biology strategies and policies worldwide. We will also hold discussions focused on the common elements, opportunities and challenges for collaborative activities and initiatives that will advance synthetic biology/engineering biology as a global enterprise and exploration into the creation of a virtual and ongoing Global Forum for Engineering Biology.

The Forum is an invitation-only event to be held at the Chaminade Resort & Spa in Santa Cruz, California, USA. Registration fee includes hotel accommodations, meals, and a reception.

TRAVEL INFORMATION

The closest airports are San Jose International Airport – SJC (34 miles) or San Francisco International Airport – SFO (62 miles).

Ground transportation to and from SJC or SFO:

Sub Shuttle (www.subshuttle.com) +1-866-256-8182

Santa Cruz On Time Airport Car (www.santacruzontimeairportshuttle.com) +1-831-421-9999

Blue Water Limo (www.bluewater.limo) +1-831-477-0170

Santa Cruz Airport Flyer (www.santacruzflyer.com)  +1- 831-423-5937

Steve Laderman

Joerg Bauer

Michelle O’Malley

Michelle A. O’Malley is an Associate Professor in the Department of Chemical Engineering at the University of California, Santa Barbara. She earned a B.S. in Chemical Engineering and Biomedical Engineering from Carnegie Mellon University in 2004 and a PhD in Chemical Engineering from the University of Delaware in 2009, where she worked with Prof. Anne Robinson to engineer overproduction of membrane proteins in yeast. O’Malley was a USDA-NIFA postdoctoral fellow in the Department of Biology at MIT and the Broad Institute, where she developed new strategies for cellulosic biofuel production. At UCSB, her research group develops synthetic biology tools to engineer protein synthesis within anaerobes and microbial consortia for sustainable chemical production, bioremediation, and natural product discovery. O’Malley’s research has been featured on NPR’s Science Friday, the BBC Newshour, the LA Times, and several other media outlets. She was named one of the 35 Top Innovators Under 35 in the world by MIT Technology Review in 2015, and is the recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE), a DOE Early Career Award, an NSF CAREER award, the Camille Dreyfus Teacher-Scholar Award, the ACS BIOT Division Young Investigator Award, the ACS PMSE Division Young Investigator Award, an ACS WCC “Rising Star” Award, and a Hellman Faculty Fellowship.

Wendell Lim

Nathan Hillson

Nathan Hillson

Dr. Hillson earned his Ph.D. in Biophysics from Harvard Medical School. He did his postdoctoral work in Developmental (Micro)Biology at Stanford University School of Medicine. Dr. Hillson's work has spanned the realms of the private (notably as co-founder/Chief Scientific Officer at TeselaGen) and public biotechnology sectors. As Department Head of BioDesign within the Biological Systems & Engineering Division, Dr. Hillson leads scientists and engineers within Lawrence Berkeley National Laboratory whose domain expertise spans synthetic biology, metabolic engineering, microbiology, microbial communities, software engineering, and laboratory automation engineering. As overall Principal Investigator of the U.S. DOE Agile Biofoundry, Dr. Hillson leads scientists/engineers across 8 U.S. DOE National Labs towards the development of a public infrastructure that enables the private sector to reduce the cost and accelerate bioprocess commercialization timelines. This infrastructure complements discovery engines (such as the Joint Genome Institute, to which Dr. Hillson also contributes).

Elisa Franco

Elisa Franco